Search research articles
Contact Us
Filters
Showing results (1-10 of 45) with videos related to
Page
of 5
Sort By:
Current Protocols in Cell Biology
|
January 30, 2008
Assessing and controlling microbial contamination in cell cultures
R Coté
Briefings in Bioinformatics
|
March 2, 2011
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases
Kui Xu, Timothy R Coté
Melanoma Research
|
May 12, 2009
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin
Timothy R Coté, Leslie H Sobin
Journal of Applied Physiology
|
January 1, 1976
Muscle water and electrolytes following varied levels of dehydration in man
D L Costill, R Coté, W Fink
Nature Reviews. Drug Discovery
|
December 2, 2010
Accelerating orphan drug development
Timothy R Coté, Kui Xu, Anne R Pariser
JAMA
|
June 9, 1993
Trends in death with tuberculosis during the AIDS era
M M Braun, T R Coté, C S Rabkin
JAMA
|
October 21, 1992
Risk of suicide among persons with AIDS. A national assessment
T R Coté, R J Biggar, A L Dannenberg
Discovery Medicine
|
April 29, 2011
Regulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials
Anne R Pariser, Kui Xu, John Milto, et al.
Medical and Pediatric Oncology
|
October 12, 2002
SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, et al.
Medical and Pediatric Oncology
|
September 5, 2002
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 45) with videos related to
Sort By:
Page
of 5
Current Protocols in Cell Biology
|
January 30, 2008
Assessing and controlling microbial contamination in cell cultures
R Coté
Briefings in Bioinformatics
|
March 2, 2011
Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases
Kui Xu, Timothy R Coté
Melanoma Research
|
May 12, 2009
Primary melanomas of the esophagus and anorectum: epidemiologic comparison with melanoma of the skin
Timothy R Coté, Leslie H Sobin
Journal of Applied Physiology
|
January 1, 1976
Muscle water and electrolytes following varied levels of dehydration in man
D L Costill, R Coté, W Fink
Nature Reviews. Drug Discovery
|
December 2, 2010
Accelerating orphan drug development
Timothy R Coté, Kui Xu, Anne R Pariser
JAMA
|
June 9, 1993
Trends in death with tuberculosis during the AIDS era
M M Braun, T R Coté, C S Rabkin
JAMA
|
October 21, 1992
Risk of suicide among persons with AIDS. A national assessment
T R Coté, R J Biggar, A L Dannenberg
Discovery Medicine
|
April 29, 2011
Regulatory considerations for developing drugs for rare diseases: orphan designations and early phase clinical trials
Anne R Pariser, Kui Xu, John Milto, et al.
Medical and Pediatric Oncology
|
October 12, 2002
SEER update of incidence and trends in pediatric malignancies: acute lymphoblastic leukemia
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, et al.
Medical and Pediatric Oncology
|
September 5, 2002
Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results
Dawn Elizabeth McNeil, Timothy R Coté, Limin Clegg, et al.
Page
of 5